BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11163229)

  • 1. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.
    de Alboran IM; O'Hagan RC; Gärtner F; Malynn B; Davidson L; Rickert R; Rajewsky K; DePinho RA; Alt FW
    Immunity; 2001 Jan; 14(1):45-55. PubMed ID: 11163229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).
    Donjerković D; Mueller CM; Scott DW
    Eur J Immunol; 2000 Apr; 30(4):1154-61. PubMed ID: 10760805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
    Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
    J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression.
    O'Hagan RC; Ohh M; David G; de Alboran IM; Alt FW; Kaelin WG; DePinho RA
    Genes Dev; 2000 Sep; 14(17):2185-91. PubMed ID: 10970882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
    EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4.
    Forssell J; Nilsson A; Sideras P
    Scand J Immunol; 1999 Feb; 49(2):155-61. PubMed ID: 10075019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life and death decisions in B1 lymphoma cells.
    Donjerković D; Carey GB; Mueller CM; Liu S; Scott DW
    Curr Top Microbiol Immunol; 2000; 252():151-9. PubMed ID: 11187083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of p27Kip1 accumulation in murine B-lymphoma cells: role of c-Myc and calcium.
    Donjerković D; Zhang L; Scott DW
    Cell Growth Differ; 1999 Oct; 10(10):695-704. PubMed ID: 10547073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition.
    Prathapam T; Tegen S; Oskarsson T; Trumpp A; Martin GS
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2695-700. PubMed ID: 16477001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG; Moses HL
    J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
    Blanchard DA; Affredou MT; Vazquez A
    J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.
    Mack FA; Patel JH; Biju MP; Haase VH; Simon MC
    Mol Cell Biol; 2005 Jun; 25(11):4565-78. PubMed ID: 15899860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death.
    de Alborán IM; Baena E; Martinez-A C
    Cell Death Differ; 2004 Jan; 11(1):61-8. PubMed ID: 12970677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Rel regulation of the cell cycle in primary mouse B lymphocytes.
    Hsia CY; Cheng S; Owyang AM; Dowdy SF; Liou HC
    Int Immunol; 2002 Aug; 14(8):905-16. PubMed ID: 12147627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
    Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.